Indication approvals and marketing authorizations for anti-TNF drugs by... | Download Table
These highlights do not include all the information needed to use REMICADE® safely and effectively. See full prescribing information for REMICADE. REMICADE (infliximab) for injection, for intravenous use Initial U.S. Approval: 1998
Biosimilar medicine fact sheet – infliximab | Australian Government Department of Health and Aged Care
REMICADE 100mg - Buy online in OGOmed
FDA Approves First Subcutaneous Infliximab for IBD
REMICADE® (infliximab) Overview | Janssen CarePath for Healthcare Professionals
Report on EU's Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar? - Page 2 of 5 - The Rheumatologist
Fuld & Company | Biosimilar Infliximab - What's All the Excitement About? - Fuld & Co
Avsola (infliximab-axxq) FDA Approval History - Drugs.com
AVSOLA®(infliximab-axxq)'s Totality of Evidence
REMICADE® (infliximab) Overview | Janssen CarePath for Healthcare Professionals
U.S., European Biosimilar Approval Activity in 2017
Infliximab
Infliximab (Remicade) Startup sheet | IBD Clinic
Samsung Bioepis and Merck Launch Renflexis® in the U.S. | Biosimilars Law Bulletin
Treating Psoriasis and Psoriatic Arthritis with Remicade : National Psoriasis Foundation
TNF-α inhibitor originators and FDA-approved biosimilars by the end of... | Download Scientific Diagram
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial - The Lancet Gastroenterology & Hepatology
J&J braces for biosim attack after losing last-ditch Remicade patent fight | Fierce Pharma
